Related Experiment Video
Updated: Dec 26, 2025
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.8K
[Parkinson's disease - heterogeneous and complex in its clinical presentation]
Filip Bergquist1, Anders Johansson2, Nil Dizdar3
1Sahlgrenska Academy - Goteborg, Sweden Sahlgrenska Academy - Goteborg, Sweden.
Lakartidningen
|March 11, 2020
Summary
Parkinson's disease, a common neurodegenerative disorder, is characterized by motor symptoms like tremors and non-motor issues. Management involves medication and deep brain stimulation, with ongoing care from a multidisciplinary team.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Parkinson's disease (PD) is the second leading neurodegenerative disorder.
- Key neuropathological hallmarks include Lewy bodies (alpha-synuclein) and dopaminergic neuron loss in the substantia nigra.
- Clinical diagnosis relies on bradykinesia, rigidity, and resting tremor, often accompanied by non-motor symptoms.
Purpose of the Study:
- To provide an overview of Parkinson's disease.
- To highlight diagnostic criteria and therapeutic approaches.
- To emphasize the progressive nature and need for continuous management.
Main Methods:
- Review of established knowledge on Parkinson's disease.
- Description of diagnostic features.
- Summary of current treatment strategies.
Main Results:
- Parkinson's disease presents with distinct motor and non-motor symptoms.
- Neuropathological findings are crucial for understanding disease mechanisms.
- Therapeutic interventions aim to manage dopaminergic deficits and symptoms.
Conclusions:
- Effective Parkinson's disease management requires a comprehensive approach.
- Treatment strategies must adapt to disease progression.
- Multidisciplinary care is essential for optimal patient outcomes.
Related Concept Videos
01:15Parkinson's Disease: Overview
1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
01:24Parkinson's Disease: Treatment
871
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
871
01:37Neural Regulation
42.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
268
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
268
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K